Naftifine

Naftifine
Clinical data
Trade names	Exoderil
AHFS/Drugs.com	Monograph
MedlinePlus	a688020
ATC code	D01AE22 (WHO) ;
Identifiers
	IUPAC name (2E)-N-methyl-N-(1-naphthylmethyl)-3-phenylprop-2-en-1-amine;
CAS Number	65472-88-0 ;
PubChem CID	47641;
DrugBank	DB00735 ;
ChemSpider	66071 ;
UNII	4FB1TON47A;
ChEBI	CHEBI:7451 ;
ChEMBL	ChEMBL626 ;
CompTox Dashboard (EPA)	DTXSID6048545 ;
Chemical and physical data
Formula	C21H21N
Molar mass	287.406 g·mol−1
	(what is this?)

Naftifine (brand name Exoderil) is an allylamine antifungal drug for the topical treatment of tinea pedis, tinea cruris, and tinea corporis (fungal infections).

Naftifine has triple action: antifungal, antibacterial and anti-inflammatory. Its precise mechanism of action is unknown, but may involve selectively blocking sterol biosynthesis via inhibition of the squalene 2,3-epoxidase enzyme.^[1]^[2] The half-life is approximately 2–3 days.^[2] The metabolites are excreted in the urine and feces.^[3]

References[]

^ Robertson Dirk B, Maibach Howard I, "Chapter 61. Dermatologic Pharmacology" (Chapter). Bertram G. Katzung, Susan B. Masters, Anthony J. Trevor: Basic & Clinical Pharmacology, 11e: http://www.accesspharmacy.com/content.aspx?aID=4517257 Archived 2012-03-03 at the Wayback Machine.
^ ^a ^b Micromedex DRUGDEX Drug Point: Naftifine Hydrochloride. Accessed at www.thomsonhc.com/../BeginWith#secN10184 Archived 2019-12-17 at the Wayback Machine, February 18, 2010.
^ AccessPharmacy: Drug Monographs: Naftifine. Accessed at http://www.accesspharmacy.com/drugContentPopup.aspx?mid=6620&section=10 Archived 2012-03-03 at the Wayback Machine, February 18, 2010.

This dermatologic drug article is a stub. You can help Wikipedia by .

[Robertson-1] Robertson Dirk B, Maibach Howard I, "Chapter 61. Dermatologic Pharmacology" (Chapter). Bertram G. Katzung, Susan B. Masters, Anthony J. Trevor: Basic & Clinical Pharmacology, 11e: http://www.accesspharmacy.com/content.aspx?aID=4517257 Archived 2012-03-03 at the Wayback Machine.

[Micromedex-2] Micromedex DRUGDEX Drug Point: Naftifine Hydrochloride. Accessed at www.thomsonhc.com/../BeginWith#secN10184 Archived 2019-12-17 at the Wayback Machine, February 18, 2010.

[3] AccessPharmacy: Drug Monographs: Naftifine. Accessed at http://www.accesspharmacy.com/drugContentPopup.aspx?mid=6620&section=10 Archived 2012-03-03 at the Wayback Machine, February 18, 2010.

[1]

[2]

[3]